Epilepsy and Gastrointestinal obstruction

Summary:

Gastrointestinal obstruction is found among people with Epilepsy, especially for people who are male, 50-59 old.

The study analyzes which people have Gastrointestinal obstruction with Epilepsy. It is created by eHealthMe based on reports of 12 people who have Epilepsy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Epilepsy?

Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures) is found to be associated with 1,166 drugs and 1,779 conditions by eHealthMe. Check the latest studies of Epilepsy.

What is Gastrointestinal obstruction?

Gastrointestinal obstruction is found to be associated with 269 drugs and 310 conditions by eHealthMe. Check the latest studies of Gastrointestinal obstruction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

12 people who have Epilepsy and Gastrointestinal Obstruction are studied.

Would you have Gastrointestinal obstruction when you have Epilepsy?

Gender of people who have Epilepsy and experienced Gastrointestinal Obstruction *:

female: 20 %
male: 80 %

Age of people who have Epilepsy and experienced Gastrointestinal Obstruction *:

Common co-existing conditions for these people *:

Lennox-Gastaut Syndrome (epilepsy characterized by frequent seizures and different seizure types): 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Sleep Disorder: 1 person, 8.33%
Partial Seizures (seizures which affect only a part of the brain at onset): 1 person, 8.33%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
Depression: 1 person, 8.33%
Cystitis Interstitial (unknown cause characterized by bladder pain): 1 person, 8.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%
Appetite Disorder (abnormal eating habits): 1 person, 8.33%

Common drugs taken by these people *:

Common symptoms for these people *:

Neoplasm Malignant (cancer tumour): 3 people, 25.00%
Electroencephalogram Abnormal: 2 people, 16.67%
Swallowing Difficulty: 2 people, 16.67%
Septic Shock (shock due to blood infection): 2 people, 16.67%
Diaphragmatic Hernia (defect or hole in the diaphragm that allows the abdominal contents to move into the chest cavity): 2 people, 16.67%
Respiratory Distress (difficulty in breathing): 2 people, 16.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 16.67%
Autonomic Failure Syndrome (a degenerative disease of the autonomic nervous system): 2 people, 16.67%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 16.67%
Cardiopulmonary Failure (cessation of normal circulation of the blood due to failure of the heart to contract): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Gastrointestinal obstruction?

- Check whether Gastrointestinal obstruction is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Gastrointestinal obstruction and Epilepsy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.